Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Phase 3 Current trial stage 2027 to 2028 Projected approval window 28.7% TRIUMPH-4 weight loss at 68 wks No NDA Filed as of May 2026 What Is Retatrutide's Current FDA Status
Research has examined its effects on c-Met receptor activation, downstream kinase signaling networks, dendritic architecture regulation, and molecular processes associated with synaptic structure and connectivity
Endocrinology 144, 51845187
PMID: 27847966 | doi:10.1007/s00109-016-1488-y Seiwerth S et al
Use the peptide reconstitution calculator to determine exact mixing ratios for your specific vial
US$ 28.34
US$ 27.62
US$ 26.67
US$ 24.43
US$ 20.80
US$ 21.27
US$ 29.81
